ID

14956

Description

A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00717951

Lien

https://clinicaltrials.gov/show/NCT00717951

Mots-clés

  1. 09/05/2016 09/05/2016 -
Téléchargé le

9 mai 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Advanced Breast Cancer NCT00717951

Eligibility Advanced Breast Cancer NCT00717951

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age≥18y
Description

age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
kps≥ 70
Description

karnofsky

Type de données

boolean

Alias
UMLS CUI [1]
C0206065
pathologic diagnosis of breast cancer
Description

breast cancer

Type de données

boolean

Alias
UMLS CUI [1]
C0678222
at least 1 measurable lesion as defined by modified recist criteria
Description

measurable lesion

Type de données

boolean

Alias
UMLS CUI [1]
C1513041
screening laboratory values with the following parameters: hemoglobin:≥10.0 g/dl absolute neutrophils count:≥1.5×109/l platelet:≥100×109/l creatinine clearance rate:
Description

laboratory values

Type de données

boolean

Alias
UMLS CUI [1]
C0019046
UMLS CUI [2]
C0948762
≥60ml/min total bilirubin: ≤1.5 ×upper limits of normal alkaline phosphatase,aspartate aminotransferase and alanine aminotransferase:≤ 2.5×upper limits of normal(≤5×upper limits of normal if liver metastasis are present)
Description

lab results

Type de données

boolean

Alias
UMLS CUI [1]
C0201913
UMLS CUI [2]
C0002059
signed informed consent
Description

informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
for women of child bearing potential,a negative serum or urine pregnancy test result before study entry.
Description

negative pregnancy test

Type de données

boolean

Alias
UMLS CUI [1]
C0427780
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
more than 2 cytotoxic chemotherapy treatment regimens for metastatic disease.
Description

chemotherapy treatment

Type de données

boolean

Alias
UMLS CUI [1]
C3665472
prior exposure to 5-fluorouracil continuous infusion.
Description

5-fluorouracil

Type de données

boolean

Alias
UMLS CUI [1]
C0016360
prior exposure docetaxol for metastatic disease
Description

docetaxol for metastatic disease

Type de données

boolean

Alias
UMLS CUI [1]
C0246415
any other cancer within 5 years prior to screening with the exception of contralateral breast cancer,adequately treated cervical carcinoma in situ,or adequately treated basal or squamous cell carcinoma of skin
Description

cancer

Type de données

boolean

Alias
UMLS CUI [1]
C0006826

Similar models

Eligibility Advanced Breast Cancer NCT00717951

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
age≥18y
boolean
C0001779 (UMLS CUI [1])
karnofsky
Item
kps≥ 70
boolean
C0206065 (UMLS CUI [1])
breast cancer
Item
pathologic diagnosis of breast cancer
boolean
C0678222 (UMLS CUI [1])
measurable lesion
Item
at least 1 measurable lesion as defined by modified recist criteria
boolean
C1513041 (UMLS CUI [1])
laboratory values
Item
screening laboratory values with the following parameters: hemoglobin:≥10.0 g/dl absolute neutrophils count:≥1.5×109/l platelet:≥100×109/l creatinine clearance rate:
boolean
C0019046 (UMLS CUI [1])
C0948762 (UMLS CUI [2])
lab results
Item
≥60ml/min total bilirubin: ≤1.5 ×upper limits of normal alkaline phosphatase,aspartate aminotransferase and alanine aminotransferase:≤ 2.5×upper limits of normal(≤5×upper limits of normal if liver metastasis are present)
boolean
C0201913 (UMLS CUI [1])
C0002059 (UMLS CUI [2])
informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
negative pregnancy test
Item
for women of child bearing potential,a negative serum or urine pregnancy test result before study entry.
boolean
C0427780 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
chemotherapy treatment
Item
more than 2 cytotoxic chemotherapy treatment regimens for metastatic disease.
boolean
C3665472 (UMLS CUI [1])
5-fluorouracil
Item
prior exposure to 5-fluorouracil continuous infusion.
boolean
C0016360 (UMLS CUI [1])
docetaxol for metastatic disease
Item
prior exposure docetaxol for metastatic disease
boolean
C0246415 (UMLS CUI [1])
cancer
Item
any other cancer within 5 years prior to screening with the exception of contralateral breast cancer,adequately treated cervical carcinoma in situ,or adequately treated basal or squamous cell carcinoma of skin
boolean
C0006826 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial